Pediatrix Medical Group has a total of 23 patents globally, out of which 2 have been granted. Of these 23 patents, more than no patents are active. Australia is where Pediatrix Medical Group has filed the maximum number of patents, followed by United States of America and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Pediatrix Medical Group.
Pediatrix Medical Group was founded in the year 1979. The Company provides maternal-fetal, newborn and pediatric physician services. The Company offers neonatal, maternal-fetal care, pediatric cardiology, pediatric intensive, pediatric emergency medicine, developmental pediatrics and newborn hearing screening services. As of April 2023, the market cap of Pediatrix Medical Group is $1.2 Billion.
Do read about some of the most popular patents of Pediatrix Medical Group which have been covered by us in this article and also you can find Pediatrix Medical Group patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pediatrix Medical Group patent portfolio.
How many patents does the CEO of Pediatrix Medical Group have?
The CEO James Swift has 3 patents.
How many patents does Pediatrix Medical Group have?
Pediatrix Medical Group has a total of 23 patents globally. These patents belong to 8 unique patent families. Out of 23 patents, 0 patents are active.
How Many Patents did Pediatrix Medical Group File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Pediatrix Medical Group Applications Filed | Pediatrix Medical Group Patents Granted |
| 2018 | 1 | – |
| 2013 | – | 1 |
| 2014 | 1 | – |
| 2009 | – | 1 |
| 2008 | 1 | – |
| 2007 | 1 | – |
| 2006 | 12 | – |
How many Pediatrix Medical Group patents are Alive/Dead?
All the Patents were filed by Pediatrix Medical Group are Dead.
How Many Patents did Pediatrix Medical Group File in Different Countries?
Countries in which Pediatrix Medical Group Filed Patents
| Country | Patents |
| Australia | 9 |
| United States Of America | 5 |
| Canada | 1 |
| Mexico | 1 |
| Brazil | 1 |
| Spain | 1 |
| Europe | 1 |
Where are Research Centres of Pediatrix Medical Group Patents Located?
What Percentage of Pediatrix Medical Group US Patent Applications were Granted?
Pediatrix Medical Group (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Pediatrix Medical Group patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Pediatrix Medical Group?
| Law Firm | Total Applications | Success Rate |
| Choate Hall & Stewart | 2 | 0.00% |
List of Pediatrix Medical Group Patents
| Pediatrix Medical Group Patents | Title |
| US8363876B2 | Audiometric Devices |
| US20180261309A1 | Methods And Systems For Estimating Costs Of Perinatological Or Neonatological Care |
| US20150025997A1 | Social Coaching System |
| US20080102535A1 | Measuring Thyroxine Levels From Dried Blood Samples Using Mass Spectrometry |
| US20060275909A1 | Nutrition Formulations And Methods Of Providing Nutrition Formulations |
| EP1890717A1 | Nutrition Formulations And Methods Of Providing Nutrition Formulations |
| WO2008057866A2 | Measuring Thyroxine Levels From Dried Blood Samples Using Mass Spectrometry |
| WO2006127761A1 | Nutrition Formulations And Methods Of Providing Nutrition Formulations |
| WO2002048697A1 | Method For Interpreting Tandem Mass Spectrometry Data For Clinical Diagnosis |
| WO2002004945A1 | Clinical Method For The Genetic Screening Of Newborns Using Tandem Mass Spectrometry |
| ES2316373T3 | Clinical Method For The Genetic Screening Of Newborns Using Tandem Mass Spectrometry |
| AU2006250072A1 | Nutrition Formulations And Methods Of Providing Nutrition Formulations |
| AU2006200475A1 | Method For Interpreting Tandem Mass Spectrometry Data For Clinical Diagnosis |
| AU2006200473A1 | Clinical Method For The Genetic Screening Of Newborns Using Tandem Mass Spectrometry |
| AU2006200477A1 | Method For Interpreting Tandem Mass Spectrometry Data For Clinical Diagnosis Of Genetic Disorders Such As Hypermethionemia |
| AU2006200472A1 | Clinical Method For The Genetic Screening Of Newborns Using Tandem Mass Spectrometry |
| AU2006200474A1 | Method For Interpreting Tandem Mass Spectrometry Data For Clinical Diagnosis Of Genetic Disorders Such As Citrullinemia |
| AU2001022609A1 | Method For Interpreting Tandem Mass Spectrometry Data For Clinical Diagnosis |
| AU2000060808A1 | Clinical Method For The Genetic Screening Of Newborns Using Tandem Mass Spectrometry |
| AU2000260808A1 | Clinical Method For The Genetic Screening Of Newborns Using Tandem Mass Spectrometry |
| MX2007014624A | Nutrition Formulations And Methods Of Providing Nutrition Formulations. |
| CA2609358A1 | Nutrition Formulations And Methods Of Providing Nutrition Formulations |
| BRPI0017383A2 | Method For Interpretation Of Tandem Mass Spectrometry Data For Clinical Diagnosis |